Artiva Biotherapeutics, Inc. (ARTV) vs Benitec Biopharma Limited (BNTC)

Artiva Biotherapeutics, Inc. and Benitec Biopharma Limited are both Biotechnology companies. Artiva Biotherapeutics, Inc. and Benitec Biopharma Limited are of similar size ($296.3M and $295.1M). Across the 9 metrics below, Benitec Biopharma Limited leads on 5 and Artiva Biotherapeutics, Inc. on 4.

Valuation

Metric ARTV BNTC Biotechnology median
P/E n/m n/m 8.50
P/S n/m 5,034.47 9.71
P/B 0.66 2.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.27 n/m 0.64
EV/Sales n/m 2,636.87 9.21
Earnings yield (56.41%) (12.08%) (33.15%)
Free cash flow yield (33.36%) (4.40%) (25.50%)

Profitability

Metric ARTV BNTC Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.58%) (33.21%) (56.36%)
Return on assets (33.76%) (32.28%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARTV BNTC Biotechnology median
Revenue growth (TTM) — (1.32%) 6.02%
EPS growth (last fiscal year) 40.96% 6.67% 30.26%
Revenue growth, 5-year CAGR — (54.02%) 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ARTV BNTC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 24.16 34.00 4.72
Net debt to EBITDA 1.24 3.52 0.96

Dividend

Metric ARTV BNTC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARTV BNTC Biotechnology median
Market cap 296.27m 295.08m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack